Product NDC: | 68968-3250 |
Proprietary Name: | STAVZOR |
Non Proprietary Name: | valproic acid |
Active Ingredient(s): | 250 mg/1 & nbsp; valproic acid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68968-3250 |
Labeler Name: | Noven Therapeutics, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022152 |
Marketing Category: | NDA |
Start Marketing Date: | 20080801 |
Package NDC: | 68968-3250-1 |
Package Description: | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68968-3250-1) |
NDC Code | 68968-3250-1 |
Proprietary Name | STAVZOR |
Package Description | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68968-3250-1) |
Product NDC | 68968-3250 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | valproic acid |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080801 |
Marketing Category Name | NDA |
Labeler Name | Noven Therapeutics, LLC |
Substance Name | VALPROIC ACID |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |